David Hering, MBA, is Regional President, North
America, Pfizer Vaccines.
Prior to this role, David was Vaccines Commercial
Officer for Pfizer Vaccines global business where he
was responsible for global commercial development,
commercial operations, business alliances –
including the partnership with Gavi, the Vaccine
Before joining Pfizer in 2015, David spent seven
years at Novartis Vaccines, where he held the
position of Head of the North America Region and
oversaw a 275-person organization consisting of
Sales, Marketing, Medical Affairs, Policy, and
Distribution across a portfolio of four vaccine assets in Meningitis and Travel. In this role, David
was responsible for the launch of Bexsero®, Novartis’s licensed meningococcal B vaccine. He
also led the transition of Novartis Vaccines to GSK as part of the acquisition announced in April
of 2014 and completed in March 2015. During the Ebola epidemic, David was selected by the
CEO of Novartis to run a unified Ebola task force response and coordinate all activities across
several divisions of the company, including internal and external communications, research
programs, grant responses, and negotiations with governments and third parties.
Prior to this role, David held positions of increasing responsibility at Novartis Vaccines, including
Vice President of US Marketing, Head Medical Countermeasures (Biodefense franchise), and
roles in US Sales, Product Market Access and Government Contracts, and Influenza Marketing.
He also worked as a Senior Consultant at Keystone Strategy prior to joining Novartis.
David started his career at Merck in Manufacturing and Finance and at 3M Company in
Consumer Product Marketing.
He earned a bachelor of science degree in operations research and industrial engineering from
Cornell University’s College of Engineering, and a master of business administration degree
from Harvard Business School.